Medicare Enrolled
Dr. Richard Locicero, M.D.
Medical Oncology · Gainesville, GA
Practice pattern: Mixed Practice
— Diverse clinical practice across multiple procedure types
Very High
DATA COVERAGE
Data in 4 of 4 federal sources
Measures public federal data availability — not provider quality
Informational, not a quality rating.
This page presents federal public records about Dr. Locicero from CMS (NPPES, Open Payments, Medicare Provider Utilization, PECOS). It is not medical advice, an endorsement, or a judgment of clinical quality. Always consult the provider directly and a licensed clinician for medical decisions. Read methodology →
Are you Dr. Locicero?
Request a correction or review of any data shown here. Provider portal →
What this data tells you about Dr. Locicero
Dr. Richard Locicero is a medical oncology specialist in Gainesville, GA, with 20 years of NPI registration. Based on federal Medicare data, Dr. Locicero performed 48,835 Medicare services in 2023. These records do not provide a deduplicated patient total.
Between the years covered by Open Payments, Dr. Locicero received a total of $10,581 from 75 pharmaceutical and/or device companies across 520 payment records. A record can group multiple payments. These transfers are publicly reported through CMS Open Payments. Disclosure alone does not establish their effect on care. A reliable breakdown by payment category is not available in this snapshot. Patients may wish to discuss these relationships with their provider.
The Data Coverage level for Dr. Locicero is Very High — reflecting how much public federal data is available about this provider. Patients are encouraged to use this data as one of several factors when choosing a healthcare provider.
✓ 20 years of NPI registration
▲ Top 22% volume in GA
$10,581 industry payments
Medicare Practice Summary — 2023
Medicare Utilization ↗48,835
Medicare services
Top 22% in GA for medical oncology
Not available
Unique patients (not deduplicated)
$9
Avg. Medicare payment
Medicare patients only (65+ / disabled) · How to read this →
Top procedures by volume
Ranked by number of services performed for Medicare patients. Avg. submitted charge is what the provider billed; avg. Medicare payment is what CMS paid.
| Procedure | Volume | Avg. paid | Avg. submitted |
|---|---|---|---|
| Iron infusion (Feraheme) An injection of ferumoxytol used to treat iron deficiency anemia in patients not on dialysis. |
23,970 | $0 | $5 |
| Denosumab injection (Prolia/Xgeva) | 8,580 | $19 | $39 |
| Anti-nausea injection (fosaprepitant) An injection of fosaprepitant, a medication used to prevent nausea and vomiting. |
6,900 | $0 | $5 |
| Dexamethasone injection (steroid) An injection of dexamethasone sodium phosphate, a corticosteroid medication, administered in a dose of 1 milligram. |
1,316 | $0 | $2 |
| Injection, granisetron hydrochloride, 100 mcg | 1,120 | $0 | $10 |
| Blood draw (venipuncture) Insertion of a needle into a vein to collect a blood sample. |
1,093 | $8 | $30 |
| Office visit, established patient (30-39 min) A follow-up office visit for an existing patient lasting between 30 and 39 minutes. The visit involves medical evaluation and management of the patient's condition. |
1,014 | $92 | $160 |
| Complete blood count (CBC) with differential An automated laboratory test that measures the levels of red blood cells, white blood cells, and platelets in the blood, including a breakdown of the different types of white blood cells. |
985 | $8 | $45 |
| Principal care management for high-risk disease, first 30 minutes This service involves 30 minutes of personal care management by a qualified healthcare professional for a patient with a single high-risk disease, billed per calendar month. |
777 | $57 | $112 |
| Comprehensive metabolic blood panel A blood test that measures a group of chemicals, including glucose, electrolytes, and kidney and liver function markers. |
699 | $10 | $65 |
| Drug injection, under skin or into muscle A procedure involving the administration of a medication or substance via injection into the subcutaneous tissue or muscle. |
273 | $10 | $40 |
| Intravenous chemotherapy infusion, 1 hour or less Administration of chemotherapy medication directly into a vein. The procedure takes one hour or less to complete. |
201 | $94 | $650 |
| Zoledronic acid injection, 1 mg An injection of zoledronic acid administered at a dose of 1 mg. |
181 | $6 | $300 |
| Enhanced Oncology Model monthly payment This code represents the monthly enhanced oncology services payment under the Enhancing Oncology Model. It covers the administrative payment for enhanced services provided to eligible patients. |
172 | $71 | $115 |
| Leuprolide acetate (for depot suspension), 7.5 mg | 153 | $126 | $1,000 |
| Additional sequential IV infusion, 1 hour or less This code represents an additional intravenous infusion administered sequentially to a primary infusion. It covers the administration time of one hour or less. |
138 | $21 | $95 |
| Annual depression screening | 138 | $17 | $40 |
| Intravenous infusion, 1 hour or less Administration of medication or fluid directly into a vein for therapeutic, preventive, or diagnostic purposes. The procedure lasts one hour or less. |
100 | $44 | $170 |
| Office visit, established patient (20-29 min) An office visit for an existing patient lasting between 20 and 29 minutes. The visit involves medical evaluation and management of the patient's condition. |
94 | $62 | $115 |
| Diphenhydramine injection, up to 50 mg An injection of diphenhydramine hydrochloride, an antihistamine medication, administered in a dose of up to 50 milligrams. |
91 | $1 | $10 |
| Irrigation of implanted venous access device This procedure involves flushing an implanted venous access device to clear blockages or maintain patency. It ensures the device remains functional for delivering medications or fluids. |
77 | $17 | $200 |
| Intravenous infusion of new drug or substance, 1 hour or less This procedure involves administering a new medication or substance directly into a vein through an existing access site. The infusion is completed within one hour or less. |
72 | $47 | $350 |
| PSA test (prostate cancer screening) | 70 | $18 | $115 |
| Thyroid stimulating hormone (TSH) test A blood test that measures the level of thyroid stimulating hormone to evaluate thyroid function. |
70 | $16 | $100 |
| Vitamin D level test A blood test to measure the amount of Vitamin D-3 in your body. |
69 | $29 | $130 |
| Subcutaneous or intramuscular chemotherapy injection This procedure involves administering anti-cancer hormonal medication through an injection into the tissue under the skin or into a muscle. |
68 | $24 | $200 |
| Additional hour of intravenous chemotherapy This code represents the administration of chemotherapy medication into a vein for each additional hour beyond the initial period. |
68 | $21 | $175 |
| Ferritin level test (iron stores) A blood test that measures the level of ferritin, a protein that stores iron in the body. |
65 | $13 | $100 |
| Free thyroxine (T4) test A blood test that measures the level of free thyroxine, a thyroid hormone, in the bloodstream. |
60 | $9 | $75 |
| Free T3 thyroid hormone test A blood test that measures the level of free triiodothyronine (T3) hormone in your body. This helps assess how well your thyroid gland is functioning. |
58 | $17 | $145 |
| Basic metabolic blood panel A blood test that measures a group of basic chemicals, including total calcium levels. |
40 | $8 | $50 |
| New patient office visit, complex (60-74 min) | 38 | $168 | $310 |
| Office visit, established patient, complex (40-54 min) An office or outpatient visit for an existing patient lasting between 40 and 54 minutes. This level of service is determined by the total time spent on the date of the encounter. |
32 | $125 | $225 |
| Carcinoembryonic antigen (CEA) level test A blood test that measures the level of carcinoembryonic antigen (CEA) protein. This test is used to monitor certain types of cancer. |
23 | $18 | $70 |
| Iron level test | 15 | $6 | $35 |
| Iron binding capacity test A blood test that measures the amount of iron in the blood and the blood's ability to bind and transport iron. |
15 | $9 | $40 |
How to read this data: This reflects Medicare patients only (typically 65+). Payment amounts are what Medicare paid the provider, not your out-of-pocket cost. These counts do not measure clinical quality or years of experience.
50.1% high complexity
38.1% medium
11.8% routine
Industry Payment Transparency
Open Payments through 2024 ↗$10,581
Total received (2018-2024)
Avg $1,512/year across 7 years
Top 34% in GA for medical oncology
A higher payment rank reflects disclosed industry relationships (consulting, research, speaking) common among subspecialists — not wrongdoing.
75
Companies
520
Payment records
Payments are publicly reported; disclosure does not establish legality · Not evidence of wrongdoing · How to interpret →
Payment categories are unavailable while the source breakdown is being rebuilt. Company and year totals do not identify how much belongs to each category.
Payment trend by year
Annual totals from pharmaceutical and medical device companies.
2024
$72
2023
$1,816
2022
$2,379
2021
$1,334
2020
$1,401
2019
$1,568
2018
$2,012
Payments by company (2024)
Eisai Inc.
$25
Daiichi Sankyo Inc.
$24
GlaxoSmithKline, LLC.
$24
Top 3 companies account for 100.0% of 2024 payments
All-time payments by company (2018-2024) ›
Novartis Pharmaceuticals Corporation
$1,215
Genentech USA, Inc.
$653
GlaxoSmithKline, LLC.
$652
E.R. Squibb & Sons, L.L.C.
$485
Amgen Inc.
$431
Celgene Corporation
$427
Merck Sharp & Dohme Corporation
$426
Daiichi Sankyo Inc.
$396
Merck Sharp & Dohme LLC
$364
PFIZER INC.
$338
Alexion Pharmaceuticals, Inc.
$275
Eisai Inc.
$270
AstraZeneca Pharmaceuticals LP
$262
Janssen Biotech, Inc.
$240
Pharmacyclics LLC, An AbbVie Company
$227
Astellas Pharma US Inc
$203
Incyte Corporation
$175
Athenex Pharmaceutical Division, LLC
$175
GENZYME CORPORATION
$152
Bayer HealthCare Pharmaceuticals Inc.
$151
TerSera Therapeutics LLC
$150
COMSORT, Inc
$150
Seagen Inc.
$137
Lilly USA, LLC
$132
EMD Serono, Inc.
$127
Gilead Sciences, Inc.
$127
EISAI INC.
$121
Rigel Pharmaceuticals, Inc.
$119
Deciphera Pharmaceuticals Inc.
$113
Boehringer Ingelheim Pharmaceuticals, Inc.
$102
Regeneron Healthcare Solutions, Inc.
$96
SANOFI-AVENTIS U.S. LLC
$90
Exelixis Inc.
$90
Kite Pharma, Inc.
$85
Pharmacyclics LLC, an AbbVie Company
$84
Coherus Biosciences Inc.
$76
Octapharma USA, Inc.
$73
JAZZ PHARMACEUTICALS INC.
$72
ARRAY BIOPHARMA INC
$68
Jazz Pharmaceuticals Inc.
$63
The Binding Site Inc.
$60
BeiGene USA, Inc.
$57
Blueprint Medicines Corporation
$55
AbbVie, Inc.
$55
Taiho Oncology, Inc.
$40
Puma Biotechnology, Inc.
$40
AbbVie Inc.
$38
Epizyme, Inc.,
$37
TOLMAR Pharmaceuticals, Inc.
$37
PUMA BIOTECHNOLOGY, INC.
$36
Helsinn Therapeutics (U.S.), Inc.
$33
Array BioPharma Inc.
$33
Shire North American Group Inc
$32
AMAG Pharmaceuticals, Inc.
$31
PharmaEssentia USA Corporation
$31
ABBVIE INC.
$29
AVEO Pharmaceuticals, Inc.
$25
Bayer Healthcare Pharmaceuticals Inc.
$25
Otsuka America Pharmaceutical, Inc.
$24
ADC Therapeutics America, Inc.
$24
Lexicon Pharmaceuticals, Inc.
$22
Organon LLC
$21
Mylan Institutional Inc.
$21
Myovant Sciences Inc.
$19
Clovis Oncology, Inc.
$19
Sun Pharmaceutical Industries Inc.
$18
RECORDATI_RARE_DISEASES_INC.
$17
TESARO, Inc.
$17
MorphoSys, US Inc.
$16
Servier Pharmaceuticals LLC
$16
Takeda Pharmaceuticals U.S.A., Inc.
$15
Dova Pharmaceuticals
$14
Seattle Genetics, Inc.
$13
MEDIVATION FIELD SOLUTIONS LLC
$11
Sirtex Medical Inc
$10
Top 3 companies account for 23.8% of all-time payments
Associated products mentioned in payments ›
ADCETRIS · AFINITOR · AKYNZEO · ALIMTA · ALOXI · AYVAKIT · Abraxane · Alecensa · Avastin · BAVENCIO · BESREMI · BEXSERO · BLENREP · BOSULIF · BRAFTOVI · BRUKINSA · Balversa · Bavencio · Braftovi · CABOMETYX · CALQUENCE · CYRAMZA · Cabometyx · DARZALEX · Doptelet · ELIGARD · EMEND · EMPLICITI · ENHERTU · ERBITUX · EVENITY · Enhertu · Erivedge · Erleada · FARYDAK · FERAHEME · FOTIVDA · FREELITE · GAVRETO · GAZYVA · GILOTRIF · Gazyva · Halaven · IBRANCE · IMBRUVICA · IMFINZI · INJECTAFER · INLYTA · INREBIC · Imbruvica · JAKAFI · JEVTANA · KANJINTI · KEYTRUDA · KISQALI · Kyprolis · LIBTAYO · LONSURF · LORBRENA · LUMAKRAS · LUTATHERA · LYNPARZA · Lenvima · Lonsurf · Lunsumio · MEKINIST · MONJUVI · NERLYNX · Neulasta · Nplate · Nubeqa · OCTAGAM IMMUNE GLOBULIN (HUMAN) · ODOMZO · ONTRUZANT · ONUREG · OPDIVO · OPDUALAG · ORGOVYX · Ogivri · PADCEV · PEMAZYRE · PIQRAY · PREVNAR 13 · PREVNAR 20 · PROMACTA · Perjeta · Pomalyst · QINLOCK · REBLOZYL · Revlimid · Rezlidhia · Rubraca · SANDOSTATIN · SCEMBLIX · SHINGRIX · SIR-Spheres Microspheres · SOLIRIS · SPRYCEL · SYLVANT · Stivarga · TAGRISSO · TASIGNA · TAZVERIK · TECENTRIQ · TIBSOVO · TUKYSA · Tavalisse · Trodelvy · Udenyca · VENCLEXTA · VERZENIO · VOTRIENT · VYXEOS · Venclexta · XOSPATA · XTANDI · Xermelo · Xofigo · ZEJULA · ZEPZELCA · ZOLADEX · Zoladex
Should you be concerned? Industry payments are disclosed through CMS Open Payments. Disclosure alone does not establish their purpose, legality, or effect on care. What matters is whether a recommended drug or device appears in your doctor's payment records. If so, consider asking your doctor about it. How to interpret this data →
Geographic Context
Medical oncologists in nearby ZIP areas
4
County median income
$77,430
Nearest hospital to ZIP centroid (approximate)
NORTHEAST GEORGIA MEDICAL CENTER, INC
0.0 mi
0.0 mi
Data Sources
| Provider Registry | ✓ NPPES | NPPES snapshot; verify current record |
| Medicare Enrollment | ✓ PECOS | PECOS snapshot |
| Practice Data | ✓ Medicare Util. | Annual (CY lag) |
| Industry Payments | ✓ Open Payments | CY 2024 |
| Disciplinary History | — Not included | N/A |
This provider has data in 4 of 4 available federal datasets, with a Data Coverage level of Very High. This reflects how much public data is available about a provider. How we calculate this →
Summary
Dr. Locicero is a mixed practice specialist, with above-average Medicare volume (top 22% in GA), with 20 years of NPI registration.
This summary is auto-generated from federal data, describing data availability and patterns. Read our methodology →
Frequently Asked Questions
Is Dr. Locicero experienced with iron infusion (feraheme)?
Based on Medicare claims data, Dr. Locicero performed 23,970 iron infusion (feraheme) services. These records cover Medicare fee-for-service activity, including eligible younger beneficiaries; they do not measure total practice volume or clinical quality.
Does Dr. Locicero receive payments from pharmaceutical companies?
Yes. Dr. Locicero received a total of $10,581 from 75 companies across 520 payment records. A record can group multiple payments. These transfers are publicly disclosed through CMS Open Payments. Disclosure alone does not establish their legality or effect on care. Patients may wish to ask their doctor about these relationships, especially if a recommended drug or device appears in the payment records.
How do Dr. Locicero's costs compare to other medical oncologists in Gainesville?
Dr. Locicero's average Medicare payment per service is $9. Note that these figures represent what Medicare pays, not your out-of-pocket cost, which depends on your specific insurance plan and deductible. Procedure-level data above shows both what was submitted and what Medicare paid for each service type.
What does Data Coverage mean?
Data Coverage (currently Very High for Dr. Locicero) measures how much public federal data is available about a provider. It is not a quality rating. A "Very High" or "High" level means the provider has data across multiple federal sources (NPPES, PECOS, Medicare Utilization, Open Payments), indicating the presence of registry, enrollment, activity or payment records, not verified experience or clinical quality. A "Low" or "Moderate" level may simply mean the provider is newer, does not see Medicare patients, or has not received any industry payments — none of which are inherently negative. Read our full methodology →
Is this data up to date?
Source publication dates and the snapshots loaded on this site can differ. Rebuilding a page does not refresh its source records. Check the Medicare reporting year and the payment interval shown above; consult the linked official sources for newer releases and current registry details. See our data freshness policy →
Explore related providers
Same specialty & city
Medical Oncologists in Gainesville
Browse medical oncologists in Gainesville ranked by procedure volume and transparency data.
Highest volume
Top Medical Oncologists in GA
Medical oncologists ranked by total Medicare services performed statewide.
Industry payments
Pharma Payments to Medical Oncologists in GA
Which GA medical oncologists receive the most from drug and device companies.
By company
Novartis Pharmaceuticals Corporation Payments to Doctors
See all physicians who received payments from Novartis Pharmaceuticals Corporation.
By company
Genentech USA, Inc. Payments to Doctors
See all physicians who received payments from Genentech USA, Inc.
By company
GlaxoSmithKline, LLC. Payments to Doctors
See all physicians who received payments from GlaxoSmithKline, LLC.
About this page
This page combines public CMS records with calculated summaries and explanatory procedure labels. These transformations are not verbatim federal records. Sources: NPPES ↗, Open Payments ↗, Medicare Provider Utilization ↗, and PECOS. Publication is mandated by the Physician Payments Sunshine Act (§6002 ACA, 42 U.S.C. §1320a-7h) and the Freedom of Information Act.
This page is not medical advice, an endorsement, a recommendation, or a quality rating. Data Coverage reflects data completeness — how much federal information exists for this provider — not clinical performance, patient outcomes, or quality of care. Always verify information directly with the provider and consult a licensed clinician before making medical decisions.
Provider corrections: Provider portal · Privacy questions: Privacy Policy · Terms: Terms of Use · Methodology: Methodology